Data‐driven approaches for tau‐PET imaging biomarkers in Alzheimer's disease
Abstract
Previous positron emission tomography (PET) studies have quantified filamentous tau pathology using regions‐of‐interest (ROIs) based on observations of the topographical distribution of neurofibrillary tangles in post‐mortem tissue. However, such approaches may not take full advantage of information contained in neuroimaging data. The present study employs an unsupervised data‐driven method to identify spatial patterns of tau‐PET distribution, and to compare these patterns to previously published “pathology‐driven” ROIs. Tau‐PET patterns were identified from a discovery sample comprised of 123 normal controls and patients with mild cognitive impairment or Alzheimer's disease (AD) dementia from the Swedish BioFINDER cohort, who underwent [18F]AV1451 PET scanning. Associations with cognition were tested in a separate sample of 90 individuals from ADNI. BioFINDER [18F]AV1451 images were entered into a robust voxelwise stable clustering algorithm, which resulted in five clusters. Mean [18F]AV1451 uptake in the data‐driven clusters, and in 35 previously published pathology‐driven ROIs, was extracted from ADNI [18F]AV1451 scans. We performed linear models comparing [18F]AV1451 signal across all 40 ROIs to tests of global cognition and episodic memory, adjusting for age, sex, and education. Two data‐driven ROIs consistently demonstrated the strongest or near‐strongest effect sizes across all cognitive tests. Inputting all regions plus demographics into a feature selection routine resulted in selection of two ROIs (one data‐driven, one pathology‐driven) and education, which together explained 28% of the variance of a global cognitive composite score. Our findings suggest that [18F]AV1451‐PET data naturally clusters into spatial patterns that are biologically meaningful and that may offer advantages as clinical tools.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 19, 2018
- Source ID
- 10.1002/hbm.24401
Entities
People
- Alan C. Evans
- Christian Dansereau
- Jacob W Vogel
- Michael Schöll
- Niklas Mattsson
- Olof T. Strandberg
- Oskar Hansson
- Philip Scheltens
- Pierre Bellec
- Rik Ossenkoppele
- Sylvia Villeneuve
- The Alzheimer’s Disease Neuroimaging Initiative*
- The Swedish Biofinder Study
- Wiesje M. Van Der Flier
- Yasser Iturria‐medina
Organizations
- Alzheimer's Disease Neuroimaging Initiative
- Canadian Institutes of Health Research
- Lund University
- McGill University
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Skåne University Hospital
- United States Department of Defense
- University of Gothenburg
- Université de Montréal
- VU University Medical Center